A genome wide dosage suppressor network reveals genetic robustness and a novel mechanism for Huntington's disease
Authors:
B. Patra,
Y. Kon,
G. Yadav,
A. W. Sevold,
J. P. Frumkin,
R. R. Vallabhajosyula,
A. Hintze,
B. Østman,
J. Schossau,
A. Bhan,
B. Marzolf,
J. K. Tamashiro,
A. Kaur,
N. S. Baliga,
E. J. Grayhack,
C. Adami,
D. J. Galas,
A. Raval,
E. M. Phizicky,
A. Ray
Abstract:
Mutational robustness is the extent to which an organism has evolved to withstand the effects of deleterious mutations. We explored the extent of mutational robustness in the budding yeast by genome wide dosage suppressor analysis of 53 conditional lethal mutations in cell division cycle and RNA synthesis related genes, revealing 660 suppressor interactions of which 642 are novel. This collection…
▽ More
Mutational robustness is the extent to which an organism has evolved to withstand the effects of deleterious mutations. We explored the extent of mutational robustness in the budding yeast by genome wide dosage suppressor analysis of 53 conditional lethal mutations in cell division cycle and RNA synthesis related genes, revealing 660 suppressor interactions of which 642 are novel. This collection has several distinctive features, including high co-occurrence of mutant-suppressor pairs within protein modules, highly correlated functions between the pairs, and higher diversity of functions among the co-suppressors than previously observed. Dosage suppression of essential genes encoding RNA polymerase subunits and chromosome cohesion complex suggest a surprising degree of functional plasticity of macromolecular complexes and the existence od degenerate pathways for circumventing potentially lethal mutations. The utility of dosage-suppressor networks is illustrated by the discovery of a novel connection between chromosome cohesion-condensation pathways involving homologous recombination, and Huntington's disease.
△ Less
Submitted 11 November, 2013;
originally announced November 2013.
